ML20151K224

From kanterella
Revision as of 07:22, 25 October 2020 by StriderTol (talk | contribs) (StriderTol Bot insert)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Change PC-01,Rev 6 to OP-1903.035, Adm Potassium Iodide
ML20151K224
Person / Time
Site: Arkansas Nuclear  Entergy icon.png
Issue date: 07/29/1997
From:
ENTERGY OPERATIONS, INC.
To:
References
NUDOCS 9708060023
Download: ML20151K224 (4)


Text

!

~, . -

Arkansas Nuclear One - Administratise Senices Document Control Tuesday, July 29,1997 Document Update Notification

= = = = = = - . = = = - _ - - - . = = = - _ - - .

COPYHOLDER NO: 103 7D: NRC - WASillNGTON ADDRESS: DOC CNTRL DESK MAIL STOP PI-37 WASIIINGTON DC 20555 DOCUMENTNO: OP-1903.035 7771E: ADM POTASSIUM lODIDE REVISIONNO: 06-01-00 CHANGE NO: PC-01 SU/1/ECT: PERMANENT CIIANGE (PC) g/

@/If this box is checked, please sign, date, and return transmittal .

in envelope provided.

ANU-1 Docket 50-313 ANO-2 Docket 50-3t18 Signature Date

= - - - _

= = - .

P DR O 00 313 PDR ' ' ' ll l

, ENTERGY OPER TIONS INCORPORATED ARKANSAS NUCLEAR ONE 1

, O rites: .o ,si.TR Tio~ o, ,or .io ,oo,oe oc, o x <>~ ~e.

1903.035 ev.

6 EXP.DATE SAFETY-RELATED N/A @YES ONO m N CONTROLLED COPY # / d ,AoE , og ,

@NO i

l PAGE CHG PAGE CHG PAGE CHG PAGE CHG 2 PC-t 3

to 4Pc.t

' Think 5

e Act 1

7 3

ieW  :

9

.. ecause Nobody's perfe 10 VERlFIED BY DATE TIME 11 O i FORM TITLE: FORM NO. REV. '

LIST OF AFFECTED PAGES 1000.006A 45

Proc > work PUW No. PROCEDURE / WORK PLAN TITLE:

PAGE: 2 of 11 1903.035 ADMINISTRATION OF POTASSIUM IODIDE nm 6 cHmE pc.g O 1.0 PURPOSE To provide guidance for the administration of Potassium Iodide (KI) to minimize uptake of radioiodines in the thyroid gland.

I i

l 2.0 SCOPE I This procedure applies to all ANO and contractor employees prior to a planned exposure to radiciodine and after an accidental exposure.

3.0 REFERENCES

l

3.1 REFERENCES

USED IN PROCEDURE PREPARATION:

3.1.1 EPA 400-R-92-001, Manual of Protective Action Guides and Protective Actions for Nuclear Incidents 3.1.2 Patient Package Insert for Commercial Packaged Potassium Iodide 3.1.3 ANO Emergency Plan

3.2 REFERENCES

USED IN CONJUNCTION WITH THIS PROCEDURE: l l

3.2.1 1903.033, " Protective Action Guidelines for Rescue / Repair

! and Damage control Teams" 3.2.2 1903.065, " Emergency Response Facility - Technical Support Center (TSC) l 3.2.3 1903.067, " Emergency Response Facility - Emergency Operations Facility (EOF) 3.3 RELATED ANO PFOCEDURES:

1903.060, "rnergency Supplies and Equipment" 1

1 7 3.4 REGULATORY CORRESPONDENCE CONTAINING NRC COMMITMENTS WHICH ARE IMPLEMENTED IN THIS PROCEDURE: Commitments noted in [ BOLD)

{

3.4.1 Letter OCNA049709 Inspection report 97-10, 6.4 NOTE

4. 0
  • DEFINITIONS None

! 5.0 RESPONSIBILITY AND AUTHORITY i

5.1 The Radiation Protection and Radwaste (RPERW) Manager is responsible for the implementation of this procedure for on-site emergency response personnel.

, 5.2 The Radiological Environmental Assessment Manager (REAM) is

' responsible for the implementation of this procedure for off-site

,1 emergency response personnel.

. -_- . - _ - . .=

PROCJWORK PUud NO. PROCEDURE / WORK PLAN TITtE:

PAGE: 4 Cf 11

  • REV: $

. 1903.035 ADMINISTRATION OF POTASSIUM IODIDE CHANGE: pg.g 6.4 DISTRIBUTION OF KI (NOTE]

KI is stored in the following locations:

y A. TSC ranergency Kit B. Onsite Radiological Monitoring Kit (located in the OSC)

C. EOF Emergency Kit D. Field Monitoring Kits (located in the EOF) l 6.4.1 Assemble the individuals who were designated to receive KI and the individuals to administer the KI 6.4.2 Provide the individuals designated to receive KI with copies of:

A. Form 1903.035A, Potassium Iodide Administration Form B. Attachment 2, Potassium Iodide Precaution Leaflet C. Form 1903.035C, ANO Medical Questionnaires Iodine Sensitivity 6.4.3 The individuals designated to administer KI should obtain copies of Form 1903.035B, KI Issue Record.

k,_- 6.4.4 Ensure personnel read and/or complete the appropriate sections of the Forms and Attachments provided in Step 6.4.2.

6.5 GUIDELINES FOR THE ADMINISTRATION OF KI NOTE The TSC Director /F0F Director can authorize the administration of KI in the field after the Field Monitoring Team members have complied with the guidelines of this procedure. Completion of the KI documentation may be accomplished later at the convenience of the TSC Director / EOF Director.

6.5.1 If possible, KI shculd be administered approximately or.e-half hour before exposure for maximum blockage.

6.5.2 Final uptake is halved if KI is administered within 3-4 hours after exposure.

l 6.5.3 Little benefit is gained with KI administration 10-12 hours after exposure.

6.5.4 Once the KI is taken and the Iodine concentration is verified or the calculated dose detenmined, the tablets should be issued for a minimum of six (6) to a maximum of ten (10) consecutive days. One tablet is issued each day.

4 g